Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 150 for

Edit search filters
  1. A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease

    Rochester, MN

  2. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

    Rochester, MN

  3. Whole-Food, Plant-Based Diet for Active Crohn’s Disease

    Rochester, MN

  4. A Study to Evaluate the Effectiveness and Safety of TD-1473 in Crohn's Disease

    Scottsdale/Phoenix, AZ

  5. The Influence of Diet on Gut Microbiotas

    Rochester, MN

  6. Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study)

    Rochester, MN

  7. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

    La Crosse, WI

  8. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis

    Rochester, MN

  9. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy

    Rochester, MN

  10. Stem Cell Fistula Plug in Perianal Crohn's Disease

    Rochester, MN

.

Mayo Clinic Footer